+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neurostimulation Devices - Global Market Outlook (2019-2027)

  • ID: 5157596
  • Report
  • September 2020
  • Region: Global
  • Stratistics Market Research Consulting Pvt Ltd

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Autonomic Technologies
  • Bioness Inc.
  • DePuy Synthes Inc.
  • LivaNova PLC
  • Neuronetics, Inc.
  • MORE
According to the report, the Global Neurostimulation Devices Market accounted for $5.61 billion in 2019 and is expected to reach $16.58 billion by 2027, growing at a CAGR of 14.5% during the forecast period.

Some of the key factors propelling the growth of the market are growing prevalence of neurological disorders, growing adoption of innovative products, and rising demand for minimally invasive surgery. However, the lack of skilled healthcare practitioners is the restraining factor for the growth of the market.

Equipment used for neuromodulation is known as neurostimulation device. This device helps in the treatment of neurologic disorders by assuring the delivery of electrical stimulation to the intended parts of the patient’s brain, peripheral nervous system, and spinal cord.

By product, the spinal cord stimulators (SCS) segment is expected to grow at a significant market share during the forecast period owing to the high market penetration of commercially available products in this segment. Based on geography, North America is anticipated to hold considerable market share during the forecast period which is attributed to the growing geriatric population, changing lifestyles, and increasing consumption of alcohol and junk food.

Some of the key players in Neurostimulation Devices Market include Medtronic, Cyberonics, boston Scientific Corporation, St. Jude Medical, Nevro Corporation, Electromedical Products International (EPI), NeuroPace, Inc., Aleva Neurotherapeutics SA, bioControl Medical, EnteroMedics Inc., bioness Inc., Autonomic Technologies, Neuronetics, Inc., Multi Radiance Medical, Inc., American Imex, Amrex Electrotherapy Equipment, Synapse biomedical, LivaNova PLC, DePuy Synthes Inc., NeuroSigma Inc., Abbott Laboratories, and Integer Holdings Corporation.

Types Covered:
  • External
  • Implantable
Products Covered:
  • Cochlear Implants (CI)
  • Spinal Cord Stimulators (SCS)
  • Deep brain Stimulators (DBS)
  • Sacral Nerve Stimulators (SNS)
  • Gastric Electric Stimulators (GES)
  • Percutaneous Tibial Nerve Stimulators
  • Auditory brainstem Implant
  • Hypoglossal Nerve Stimulation
  • Transcranial Magnetic Stimulators
  • Vagus Nerve Stimulators (VNS)
End-users Covered:
  • Hospitals
  • Research Institutes/Scientific Research Laboratories
  • Cognitive Care Centers
  • Rehabilitation Centers
  • Medical Clinic
  • Ambulatory Surgery Centers
  • Specialty Clinics
Applications Covered:
  • Neurological Disorders
  • Chronic Pain
  • Movement Disorders
  • Ischemia
  • Treatment Resistant Depression(TRD)
  • Obsessive Compulsive Disorder(OCD)
  • Hearing Loss
  • Gastroparesis
  • Pain Management
  • Neurologic Urinary and Fecal Incontinence
  • Essential Tremor
  • Depressive Disorder
  • Dystonia
  • Respiratory Disorders
Regions Covered:

North America
  • US
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia-Pacific
South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings

Purchasers of this report will be entitled to receive one of the following free customization options:

1. Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
2. Regional Segmentation
  • Market estimations, forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
3. Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Autonomic Technologies
  • Bioness Inc.
  • DePuy Synthes Inc.
  • LivaNova PLC
  • Neuronetics, Inc.
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End-user Analysis
3.9 Emerging Markets
3.10 Impact of COVID-19

4 Porters Five Forces Analysis
4.1 Bargaining Power of Suppliers
4.2 Bargaining Power of Buyers
4.3 Threat of Substitutes
4.4 Threat of New Entrants
4.5 Competitive Rivalry

5 Global Neurostimulation Devices Market, By Type
5.1 Introduction
5.2 External
5.2.1 Transcranial Magnetic Stimulation (TMS)
5.2.2 Transcutaneous Electrical Nerve Stimulation (TENS)
5.3 Implantable

6 Global Neurostimulation Devices Market, By Product
6.1 Introduction
6.2 Cochlear Implants (CI)
6.3 Spinal Cord Stimulators (SCS)
6.4 Deep Brain Stimulators (DBS)
6.5 Sacral Nerve Stimulators (SNS)
6.6 Gastric Electric Stimulators (GES)
6.7 Percutaneous Tibial Nerve Stimulators
6.8 Auditory Brainstem Implant
6.9 Hypoglossal Nerve Stimulation
6.10 Transcranial Magnetic Stimulators
6.11 Vagus Nerve Stimulators (VNS)
6.11.1 Noninvasive Vagus Nerve Stimulator
6.11.2 Invasive Vagus Nerve Stimulator

7 Global Neurostimulation Devices Market, By End-user
7.1 Introduction
7.2 Hospitals
7.3 Research Institutes/Scientific Research Laboratories
7.4 Cognitive Care Centers
7.5 Rehabilitation Centers
7.6 Medical Clinic
7.7 Ambulatory Surgery Centers
7.8 Specialty Clinics

8 Global Neurostimulation Devices Market, By Application
8.1 Introduction
8.2 Neurological Disorders
8.2.1 Alzheimer’s
8.2.2 Epilepsy
8.2.3 Parkinson's Disease
8.3 Chronic Pain
8.4 Movement Disorders
8.5 Ischemia
8.6 Treatment Resistant Depression(TRD)
8.7 Obsessive Compulsive Disorder(OCD)
8.8 Hearing Loss
8.9 Gastroparesis
8.10 Pain Management
8.11 Neurologic Urinary and Fecal Incontinence
8.12 Essential Tremor
8.13 Depressive Disorder
8.14 Dystonia
8.15 Respiratory Disorders

9 Global Neurostimulation Devices Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia-Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launches
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Medtronic
11.2 Cyberonics
11.3 Boston Scientific Corporation
11.4 St. Jude Medical
11.5 Nevro Corporation
11.6 Electromedical Products International (EPI)
11.7 NeuroPace, Inc.
11.8 Aleva Neurotherapeutics SA
11.9 BioControl Medical
11.10 EnteroMedics Inc.
11.11 Bioness Inc.
11.12 Autonomic Technologies
11.13 Neuronetics, Inc.
11.14 Multi Radiance Medical, Inc.
11.15 American Imex
11.16 Amrex Electrotherapy Equipment
11.17 Synapse Biomedical
11.18 LivaNova PLC
11.19 DePuy Synthes Inc.
11.20 NeuroSigma Inc.
11.21 Abbott Laboratories
11.22 Integer Holdings Corporation

List of Tables
Table 1 Global Neurostimulation Devices Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Neurostimulation Devices Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Neurostimulation Devices Market Outlook, By External (2018-2027) ($MN)
Table 4 Global Neurostimulation Devices Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2018-2027) ($MN)
Table 5 Global Neurostimulation Devices Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2018-2027) ($MN)
Table 6 Global Neurostimulation Devices Market Outlook, By Implantable (2018-2027) ($MN)
Table 7 Global Neurostimulation Devices Market Outlook, By Product (2018-2027) ($MN)
Table 8 Global Neurostimulation Devices Market Outlook, By Cochlear Implants (CI) (2018-2027) ($MN)
Table 9 Global Neurostimulation Devices Market Outlook, By Spinal Cord Stimulators (SCS) (2018-2027) ($MN)
Table 10 Global Neurostimulation Devices Market Outlook, By Deep Brain Stimulators (DBS) (2018-2027) ($MN)
Table 11 Global Neurostimulation Devices Market Outlook, By Sacral Nerve Stimulators (SNS) (2018-2027) ($MN)
Table 12 Global Neurostimulation Devices Market Outlook, By Gastric Electric Stimulators (GES) (2018-2027) ($MN)
Table 13 Global Neurostimulation Devices Market Outlook, By Percutaneous Tibial Nerve Stimulators (2018-2027) ($MN)
Table 14 Global Neurostimulation Devices Market Outlook, By Auditory Brainstem Implant (2018-2027) ($MN)
Table 15 Global Neurostimulation Devices Market Outlook, By Hypoglossal Nerve Stimulation (2018-2027) ($MN)
Table 16 Global Neurostimulation Devices Market Outlook, By Transcranial Magnetic Stimulators (2018-2027) ($MN)
Table 17 Global Neurostimulation Devices Market Outlook, By Vagus Nerve Stimulators (VNS) (2018-2027) ($MN)
Table 18 Global Neurostimulation Devices Market Outlook, By Noninvasive Vagus Nerve Stimulator (2018-2027) ($MN)
Table 19 Global Neurostimulation Devices Market Outlook, By Invasive Vagus Nerve Stimulator (2018-2027) ($MN)
Table 20 Global Neurostimulation Devices Market Outlook, By End-user (2018-2027) ($MN)
Table 21 Global Neurostimulation Devices Market Outlook, By Hospitals (2018-2027) ($MN)
Table 22 Global Neurostimulation Devices Market Outlook, By Research Institutes/Scientific Research Laboratories (2018-2027) ($MN)
Table 23 Global Neurostimulation Devices Market Outlook, By Cognitive Care Centers (2018-2027) ($MN)
Table 24 Global Neurostimulation Devices Market Outlook, By Rehabilitation Centers (2018-2027) ($MN)
Table 25 Global Neurostimulation Devices Market Outlook, By Medical Clinic (2018-2027) ($MN)
Table 26 Global Neurostimulation Devices Market Outlook, By Ambulatory Surgery Centers (2018-2027) ($MN)
Table 27 Global Neurostimulation Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
Table 28 Global Neurostimulation Devices Market Outlook, By Application (2018-2027) ($MN)
Table 29 Global Neurostimulation Devices Market Outlook, By Neurological Disorders (2018-2027) ($MN)
Table 30 Global Neurostimulation Devices Market Outlook, By Alzheimer’s (2018-2027) ($MN)
Table 31 Global Neurostimulation Devices Market Outlook, By Epilepsy (2018-2027) ($MN)
Table 32 Global Neurostimulation Devices Market Outlook, By Parkinson's Disease (2018-2027) ($MN)
Table 33 Global Neurostimulation Devices Market Outlook, By Chronic Pain (2018-2027) ($MN)
Table 34 Global Neurostimulation Devices Market Outlook, By Movement Disorders (2018-2027) ($MN)
Table 35 Global Neurostimulation Devices Market Outlook, By Ischemia (2018-2027) ($MN)
Table 36 Global Neurostimulation Devices Market Outlook, By Treatment Resistant Depression(TRD) (2018-2027) ($MN)
Table 37 Global Neurostimulation Devices Market Outlook, By Obsessive Compulsive Disorder(OCD) (2018-2027) ($MN)
Table 38 Global Neurostimulation Devices Market Outlook, By Hearing Loss (2018-2027) ($MN)
Table 39 Global Neurostimulation Devices Market Outlook, By Gastroparesis (2018-2027) ($MN)
Table 40 Global Neurostimulation Devices Market Outlook, By Pain Management (2018-2027) ($MN)
Table 41 Global Neurostimulation Devices Market Outlook, By Neurologic Urinary and Fecal Incontinence (2018-2027) ($MN)
Table 42 Global Neurostimulation Devices Market Outlook, By Essential Tremor (2018-2027) ($MN)
Table 43 Global Neurostimulation Devices Market Outlook, By Depressive Disorder (2018-2027) ($MN)
Table 44 Global Neurostimulation Devices Market Outlook, By Dystonia (2018-2027) ($MN)
Table 45 Global Neurostimulation Devices Market Outlook, By Respiratory Disorders (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above
Note: Product cover images may vary from those shown
  • Medtronic
  • Cyberonics
  • Boston Scientific Corporation
  • St. Jude Medical
  • Nevro Corporation
  • Electromedical Products International (EPI)
  • NeuroPace, Inc.
  • Aleva Neurotherapeutics SA
  • BioControl Medical
  • EnteroMedics Inc.
  • Bioness Inc.
  • Autonomic Technologies
  • Neuronetics, Inc.
  • Multi Radiance Medical, Inc.
  • American Imex
  • Amrex Electrotherapy Equipment
  • Synapse Biomedical
  • LivaNova PLC
  • DePuy Synthes Inc.
  • NeuroSigma Inc.
  • Abbott Laboratories
  • Integer Holdings Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll